Activation of Mitophagy by Kinetin Mitigates Coal–Silica Mixed Dust-Induced Pulmonary Fibrosis via Modulating Macrophage Mitochondrial Function in Mice
Restricted accessResearch articleFirst published online April, 2026
Activation of Mitophagy by Kinetin Mitigates Coal–Silica Mixed Dust-Induced Pulmonary Fibrosis via Modulating Macrophage Mitochondrial Function in Mice
Coal workers’ pneumoconiosis (CWP) is an occupational lung disease caused by the inhalation of coal dust. A key underlying pathogenic mechanism is driven by mitochondrial dysfunction and excessive reactive oxygen species (ROS), which trigger macrophage inflammation and cell death. Damaged mitochondria are selectively degraded via mitophagy, a process essential for maintaining mitochondrial homeostasis and promoting cell survival. However, the role of mitophagy dysregulation in dust-induced mitochondrial dysfunction and the underlying treatment with kinetin remain unclear. This study aimed to explore the role of PINK1/Parkin-mediated mitophagy in coal–silica mixed dust (CSD)-induced mitochondrial damage and to investigate the therapeutic potential of kinetin in targeting this pathway.
Results:
In this study, we compared the effects of CSD exposure and kinetin treatment on mitophagy, mitochondrial function, inflammation, and pulmonary fibrosis. We found that CSD exposure triggered ROS accumulation, mitochondrial membrane potential collapse, and impaired oxidative phosphorylation, leading to reduced adenosine triphosphate synthesis. Mechanistically, CSD suppressed PINK1/Parkin signaling and diminished LC3B mitochondrial recruitment, resulting in defective mitophagy. Notably, kinetin treatment and PINK1 overexpression restored PINK1/Parkin activation and LC3II-dependent mitophagy, alleviated mitochondrial dysfunction, and suppressed subsequent macrophage inflammation and pulmonary fibrosis. Genetic knockdown of PINK1 abolished the protective effects of kinetin, confirming a PINK1-dependent mechanism.
Innovation:
Our results revealed that kinetin is a PINK1-dependent mitophagy activator, positioning it as a promising therapeutic candidate for CWP by targeting mitochondrial integrity.
Conclusion:
Kinetin exerts its antifibrotic effects on CWP by promoting PINK1-mediated mitophagy, improving mitochondrial function, and alleviating macrophage inflammation. Antioxid. Redox Signal. 44, 528–549.
Abdel-LatifR, FathyM, AnwarHA, et al.Cisplatin-induced reproductive toxicity and oxidative stress: Ameliorative effect of kinetin. Antioxidants (Basel), 2022; 11(5):863.
2.
AmasinoR. 1955: Kinetin arrives: The 50th anniversary of a new plant hormone. Plant Physiol, 2005; 138(3):1177–1184.
3.
AnS, ChaHJ, KoJM, et al.Kinetin improves barrier function of the skin by modulating keratinocyte differentiation markers. Ann Dermatol, 2017; 29(1):6–12.
4.
AndersonA, AlfahadN, WimalachandraD, et al.Relaxation of mitochondrial hyperfusion in the diabetic retina via N6-furfuryladenosine confers neuroprotection regardless of glycaemic status. Nat Commun, 2024; 15(1):1124.
5.
ArayaJ, KojimaJ, TakasakaN, et al.Insufficient autophagy in idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol, 2013; 304(1):L56–L69.
6.
AxelrodFB, LiebesL, Gold-Von SimsonG, et al.Kinetin improves IKBKAP mRNA splicing in patients with familial dysautonomia. Pediatr Res, 2011; 70(5):480–483.
7.
BainesCP, KaiserRA, PurcellNH, et al.Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature, 2005; 434(7033):658–662.
8.
BronnerDN, O’riordanMX. Measurement of mitochondrial DNA release in response to ER stress. Bio Protoc, 2016; 6(12):e1839.
9.
BryantJD, LeiY, VanportflietJJ, et al.Assessing mitochondrial DNA release into the cytosol and subsequent activation of innate immune-related pathways in mammalian cells. Curr Protoc, 2022; 2(2):e372.
10.
BuenoM, CalyecaJ, RojasM, et al.Mitochondria dysfunction and metabolic reprogramming as drivers of idiopathic pulmonary fibrosis. Redox Biol, 2020; 33:101509.
11.
BuenoM, LaiYC, RomeroY, et al.PINK1 deficiency impairs mitochondrial homeostasis and promotes lung fibrosis. J Clin Invest, 2015; 125(2):521–538.
12.
Cala-GarciaJD, Medina-RinconGJ, Sierra-SalasPA, et al.The role of mitochondrial dysfunction in idiopathic pulmonary fibrosis: New perspectives for a challenging disease. Biology (Basel), 2023; 12(9):1237.
13.
D’arcyMS. Mitophagy in health and disease. Molecular mechanisms, regulatory pathways, and therapeutic implications. Apoptosis, 2024; 29:1415–1428.
14.
Degli EspostiM. Did mitophagy follow the origin of mitochondria? Autophagy, 2024; 20(5):985–993.
15.
DostertC, PétrilliV, Van BruggenR, et al.Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science, 2008; 320(5876):674–677.
16.
GiordanoL, WareSA, LagranhaCJ, et al.Mitochondrial DNA signals driving immune responses: Why, How, Where? Cell Commun Signal, 2025; 23(1):192.
17.
Gold-Von SimsonG, GoldbergJD, RolnitzkyLM, et al.Kinetin in familial dysautonomia carriers: Implications for a new therapeutic strategy targeting mRNA splicing. Pediatr Res, 2009; 65:341–346.
18.
GuptaS, CasselSL, SutterwalaFS, et al.Regulation of the NLRP3 inflammasome by autophagy and mitophagy. Immunol Rev, 2025; 329(1):e13410.
19.
HertzNT, BerthetA, SosML, et al.A neo-substrate that amplifies catalytic activity of parkinson’s-disease-related kinase PINK1. Cell, 2013; 154(4):737–747.
20.
HsiaoG, ShenMY, LinKH, et al.Inhibitory activity of kinetin on free radical formation of activated platelets in vitro and on thrombus formation in vivo. Eur J Pharmacol, 2003; 465(3):281–287.
21.
HübnerRH, GitterW, El MokhtariNE, et al.Standardized quantification of pulmonary fibrosis in histological samples. Biotechniques, 2008; 44(4):507–11, 514–7.
22.
JinFC, ChenJJ, XuQX, et al.Kinetin inhibits hepatic stellate cell activation and induces apoptosis via interactions with the TGF-β1/Smad signaling pathway. Toxicol Appl Pharmacol, 2023; 475:116655.
23.
KadlecováA, MakováB, Artal-SanzM, et al.The plant hormone kinetin in disease therapy and healthy aging. Ageing Res Rev, 2019; 55:100958.
24.
KobayashiK, ArayaJ, MinagawaS, et al.Involvement of PARK2-mediated mitophagy in idiopathic pulmonary fibrosis pathogenesis. J Immunol, 2016; 197(2):504–516.
25.
LamJ, KattiP, BieteM, et al.A Universal approach to analyzing transmission electron microscopy with ImageJ. Cells, 2021; 10(9):2177.
26.
LambourneOA, BellS, WilhelmLP, et al.PINK1-dependent mitophagy inhibits elevated ubiquitin phosphorylation caused by mitochondrial damage. J Med Chem, 2023; 66(11):7645–7656.
27.
Larson-CaseyJL, HeC, CarterAB. Mitochondrial quality control in pulmonary fibrosis. Redox Biol, 2020; 33:101426.
28.
LiZ, PanH, YangJ, et al.Xuanfei Baidu formula alleviates impaired mitochondrial dynamics and activated NLRP3 inflammasome by repressing NF-κB and MAPK pathways in LPS-induced ALI and inflammation models. Phytomedicine, 2023; 108:154545.
29.
LiuH, SunY, XuH, et al.PTEN-induced putative kinase 1 regulates mitochondrial quality control and is essential for the maturation of human induced pluripotent stem cell-derived cardiomyocytes. Genes Dis, 2023; 10(5):2151–2166.
30.
LiuL, LiaoX, WuH, et al.Mitophagy and its contribution to metabolic and aging-associated disorders. Antioxid Redox Signal, 2020; 32(12):906–927.
31.
MarroccoA, FrawleyK, PearceLL, et al.Metabolic adaptation of macrophages as mechanism of defense against crystalline silica. J Immunol, 2021; 207(6):1627–1640.
32.
MecozziL, MambriniM, RuscittiF, et al.In-vivo lung fibrosis staging in a bleomycin-mouse model: A new micro-CT guided densitometric approach. Sci Rep, 2020; 10(1):18735.
33.
MiaoR, JiangC, ChangWY, et al.Gasdermin D permeabilization of mitochondrial inner and outer membranes accelerates and enhances pyroptosis. Immunity, 2023; 56(11):2523–2541.e8.
34.
MurphyDM, MetzgerLF, SilageDA, et al.Effect of simple anthracite pneumoconiosis on lung mechanics. Chest, 1982; 82(6):744–750.
35.
MurphyMP. How mitochondria produce reactive oxygen species. Biochem J, 2009; 417(1):1–13.
36.
NakahiraK, HaspelJA, RathinamVA, et al.Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol, 2011; 12(3):222–230.
37.
NarendraDP, YouleRJ. The role of PINK1-Parkin in mitochondrial quality control. Nat Cell Biol, 2024; 26(10):1639–1651.
38.
NewmanLE, ShadelGS. Mitochondrial DNA release in innate immune signaling. Annu Rev Biochem, 2023; 92:299–332.
39.
OrnatowskiW, LuQ, YegambaramM, et al.Complex interplay between autophagy and oxidative stress in the development of pulmonary disease. Redox Biol, 2020; 36:101679.
40.
OsgerbyL, LaiYC, ThorntonPJ, et al.Kinetin riboside and its proTides activate the Parkinson’s disease associated PTEN-induced putative kinase 1 (PINK1) independent of mitochondrial depolarization. J Med Chem, 2017; 60(8):3518–3524.
41.
PanX, ZhaoY, LiY, et al.Mitochondrial dynamics govern whole-body regeneration through stem cell pluripotency and mitonuclear balance. Nat Commun, 2024; 15(1):10681.
42.
PatelAS, SongJW, ChuSG, et al.Epithelial cell mitochondrial dysfunction and PINK1 are induced by transforming growth factor-beta1 in pulmonary fibrosis. PLoS One, 2015; 10(3):e0121246.
43.
PokharelMD, Garcia-FloresA, MarcianoD, et al.Mitochondrial network dynamics in pulmonary disease: Bridging the gap between inflammation, oxidative stress, and bioenergetics. Redox Biol, 2024; 70:103049.
44.
SartiP, AreseM, BacchiA, et al.Nitric oxide and mitochondrial complex IV. IUBMB Life, 2003; 55(10–11):605–611.
ShekarianY, RahimiE, RezaeeM, et al.Respirable coal mine dust: A review of respiratory deposition, regulations, and characterization. Minerals, 2021; 11(7):696.
47.
SongS, FuZ, GuanR, et al.Intracellular hydroxyproline imprinting following resolution of bleomycin-induced pulmonary fibrosis. Eur Respir J, 2022; 59(5):2100864.
48.
SouzaTML, PinhoVD, SetimCF, et al.Preclinical development of kinetin as a safe error-prone SARS-CoV-2 antiviral able to attenuate virus-induced inflammation. Nat Commun, 2023; 14(1):199.
49.
TaylorER, HurrellF, ShannonRJ, et al.Reversible glutathionylation of complex I increases mitochondrial superoxide formation. J Biol Chem, 2003; 278(22):19603–19610.
50.
ThornfeldtCR, RizerRL. Superior efficacy of an herbal-based cosmeceutical compared with common prescription and cosmetic antiaging therapies. J Drugs Dermatol, 2016; 15(2):218–223.
51.
VankaKS, ShuklaS, GomezHM, et al.Understanding the pathogenesis of occupational coal and silica dust-associated lung disease. Eur Respir Rev, 2022; 31(165):210250.
52.
WangD, LiangR, YangM, et al.Incidence and disease burden of coal workers’ pneumoconiosis worldwide, 1990–2019: Evidence from the Global Burden of Disease Study 2019. Eur Respir J, 2021; 58(5):2101669.
53.
WangY, HuLF, LiuNH, et al.Mitophagy-enhanced nanoparticle-engineered mitochondria restore homeostasis of mitochondrial pool for alleviating pulmonary Fibrosis. ACS Nano, 2024; 18(47):32705–32722.
54.
WeiY, YouY, ZhangJ, et al.Crystalline silica-induced macrophage pyroptosis interacting with mitophagy contributes to pulmonary fibrosis via modulating mitochondria homeostasis. J Hazard Mater, 2023; 454:131562.
55.
WhiteMJ, McarthurK, MetcalfD, et al.Apoptotic caspases suppress mtDNA-induced STING-mediated type I IFN production. Cell, 2014; 159(7):1549–1562.
56.
WynnTA, VannellaKM. Macrophages in tissue repair, regeneration, and fibrosis. Immunity, 2016; 44(3):450–462.
57.
XianH, WatariK, Sanchez-LopezE, et al.Oxidized DNA fragments exit mitochondria via mPTP- and VDAC-dependent channels to activate NLRP3 inflammasome and interferon signaling. Immunity, 2022; 55(8):1370–1385.e8.
58.
XiaoCY, TangY, RenT, et al.Treatment of silicosis with quercetin depolarizing macrophages via inhibition of mitochondrial damage-associated pyroptosis. Ecotoxicol Environ Saf, 2024; 286:117161.
59.
YamashitaSI, SugiuraY, MatsuokaY, et al.Mitophagy mediated by BNIP3 and NIX protects against ferroptosis by downregulating mitochondrial reactive oxygen species. Cell Death Differ, 2024; 31(5):651–661.
ZhangY, FangQ, WangH, et al.Increased mitophagy protects cochlear hair cells from aminoglycoside-induced damage. Autophagy, 2023; 19(1):75–91.
62.
ZhangY, LiangJ, CaoN, et al.Coal dust nanoparticles induced pulmonary fibrosis by promoting inflammation and epithelial-mesenchymal transition via the NF-κB/NLRP3 pathway driven by IGF1/ROS-mediated AKT/GSK3β signals. Cell Death Discov, 2022; 8(1):500.
63.
ZhangZQ, ZhangCZ, ShaoB, et al.Effects of abnormal expression of fusion and fission genes on the morphology and function of lung macrophage mitochondria in SiO(2)-induced silicosis fibrosis in rats in vivo. Toxicol Lett, 2019; 312:181–187.
64.
ZhouQ, YiG, ChangM, et al.Activation of Sirtuin3 by honokiol ameliorates alveolar epithelial cell senescence in experimental silicosis via the cGAS-STING pathway. Redox Biol, 2024; 74:103224.
65.
ZhouR, YazdiAS, MenuP, et al.A role for mitochondria in NLRP3 inflammasome activation. Nature, 2011; 469(7329):221–225.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
